Skip to main content
OpenTrials
Completed

NCT Number: NCT02811952

Measuring Urinary Nano Particles and Metallic Compounds in TCC Patients

In many of urothelial carcinoma patients, one does not find common risk factors such as smoking. The medical center is located in an industrial city with known air and water pollution. The investigators decided to check the presence of nano particles and traces of metals in urinary samples of patients known and suspected for urothelial carcinoma and compare the results to both cystoscopic and cytological findings. The patients will fill a validated epidemiological respiratory disease survey and the results will be compared to a control group.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Bladder Cancer Female Urogenital Diseases Female Urogenital Diseases and Pregnancy Complications Male Urogenital Diseases Neoplasms Neoplasms by Site Urinary Bladder Diseases Urinary Bladder Neoplasms Urogenital Diseases Urogenital Neoplasms Urologic Diseases Urologic Neoplasms

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Carmel Lady Davis Medical Center

Haifa, Israel

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Study group :

  • Patients that need cystoscopy due to suspicion/known bladder malignancy.
  • Patients that can read, understand and sign an informed consent form.

Control group:

  • Patients that need cystoscopy due to others reasons than malignancy.
  • Patients that present to the Department of Urology for surgery unrelated to malignancy of the urinary system ( prostatectomy, Incontinence repair, circumcision, hydrocele/ varicocele repair, ureteroscopy etc).

Exclusion criteria

Study group:

  • Patients receiving bladder irrigations, pregnant women, children and those with impaired judgment
  • Patients with a technically improper urine test.

Control group

  • Patients receiving bladder irrigations, pregnant women, children and those with impaired judgment
  • Patients with a technically improper urine test.

Treatment and study plan

without intervention

Other

without intervention

Primary outcomes

  1. levels of nano particles and arsenic in urine

    Time frame: one year

Sponsors and collaborators

Lead sponsor

Carmel Medical Center

Other

Registry information

Official study title

Measuring Urinary Nano Particles and Arsenic and Comparing Them to Cystoscopic Findings and Urinary Cytology in Patients Suspected With Urinary Bladder Malignancy

Important dates

Study start
2016
Primary completion
2020
Study completion
2021
First posted
Jun 23, 2016
Registry last updated
Oct 14, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.